PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35348007-1	2022	Hypertension characterized by low circulating renin activity accounts for roughly 25-30% of primary hypertension in humans and can be modeled experimentally via deoxycorticosterone acetate (DOCA)-salt treatment.	Desoxycorticosterone Acetate	190-194	renin	Homo sapiens	46-51	
35348007-1	2022	Hypertension characterized by low circulating renin activity accounts for roughly 25-30% of primary hypertension in humans and can be modeled experimentally via deoxycorticosterone acetate (DOCA)-salt treatment.	Desoxycorticosterone Acetate	161-188	renin	Homo sapiens	46-51	
6999497-0	1980	Deoxycorticosterone acetate-induced renin suppression in the absence of antidiuretic hormone.	Desoxycorticosterone Acetate	0-27	renin	Homo sapiens	36-41	
573464-3	1979	The juxtaglomerular renin activity and tubuloglomerular feedback response were inhibited acutely, by saline expansion, or chronically, by DOCA-treatment with saline drinking fluid or salt diet, by high salt diet alone, or by inducing two-kidney Goldblatt hypertension.	Desoxycorticosterone Acetate	138-142	renin	Homo sapiens	20-25	
397714-2	1979	Infants with the salt-losing form had high plasma renin activity levels 5--11 months after subcutaneous implantation of a pellet containing 100 mg deoxycorticosterone acetate.	Desoxycorticosterone Acetate	147-174	renin	Homo sapiens	50-55	
397714-3	1979	These elevated plasma renin activity levels were suppressed to the normal range by repeated implantation of DOCA pellet.	Desoxycorticosterone Acetate	108-112	renin	Homo sapiens	22-27	
21263123-3	2011	Previous studies have demonstrated that DOCA-salt hypertension is mediated through activation of the brain renin-angiotensin system.	Desoxycorticosterone Acetate	40-44	renin	Homo sapiens	107-112	
754801-0	1978	[Behavior of plasma renin activity (PRA) after administration of DOCA in normal subjects].	Desoxycorticosterone Acetate	65-69	renin	Homo sapiens	20-25	
754804-0	1978	[Blood aldosterone levels and plasma renin activity after administration of DOCA].	Desoxycorticosterone Acetate	76-80	renin	Homo sapiens	37-42	
1127075-0	1975	Suppression of renin and aldosterone by small amounts of DOCA in normal man.	Desoxycorticosterone Acetate	57-61	renin	Homo sapiens	15-20	
26119848-4	2015	This is particularly important because increased oxidative stress plays a major role in the DOCA-salt hypertension model, which is less dependent on activation of the renin-angiotensin system than other hypertension models.	Desoxycorticosterone Acetate	92-96	renin	Homo sapiens	167-172